Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.



Date Headline/Title
08 December 2023Appointment of Group Company Secretary
07 December 2023Report on Annual General Meeting Proceedings
06 December 2023Completion of the Acquisition of Distribution and Promotion Rights from Lilly
04 December 2023Aspen reaches Agreement on two transactions with Sandoz
27 November 2023Reminder: Manufacturing Day & Aspen Notre-Dame-De-Bondeville Site Visit – 29th November 2023
01 November 2023Completion of the Acquisition of a Portfolio of Products in Latin America from Viatris
27 October 2023Release of Integrated Report, B-BBEE Verification Certificate and Further Notice of Annual General Meeting
27 October 2023Manufacturing day & Aspen Notre-Dame-De-Bondeville site visit – 29th November 2023
23 October 2023Vesting of Securities for Directors, Company Secretary and Prescribed Officers of the Company
04 October 2023No Change Statement and Notice of Annual General Meeting – 7 December 2023
27 September 2023Notification in terms of section 122(3) of the Companies Act and paragraph 3.83(b) of the JSE Listings Requirements
27 September 2023Dealings in Securities by Directors, Prescribed Officers and the Company Secretary of the Company
19 September 2023Contract Manufacturing Agreement To Initiate Local Production Of Human Insulin For Novo Nordisk
06 September 2023Correction: Contract Manufacturing Agreement to Initiate Local Production of Medicine to Treat a Chronic Disease
06 September 2023Contract Manufacturing Agreement to Initiate Local Production of an Essential Medicine to treat a Chronic Disease
30 August 2023Aspen final results June 2023
30 August 2023Aspen secures Distribution and Promotion Rights in South Africa and Certain Sub-Saharan African Countries from Lilly
17 August 2023Reminder of the Release of the Annual Financial Results for the Year ended 30 June 2023 and a Live Presentation
01 August 2023Acquisition of a Portfolio of Products in Latin America from Viatris
14 June 2023Changes to the Aspen Board Committees
29 May 2023Resignation of Ms Babalwa Ngonyama
04 May 2023Aspen secures distribution rights in South Africa from Amgen
13 March 2023Notification in terms of section 122(3) of the Companies Act and paragraph 3.83(b) of the JSE Listings Requirements
01 March 2023Aspen interim results December 2022
17 February 2023Aspen’s Interim Results for the six months ended 31 December 2022 and Results presentation reminder
30 January 2023Passing of Company Secretary: Riaan Verster
Powered by ProfileData